We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.9M
AUM Growth
+$16.2M
Cap. Flow
+$13.7M
Cap. Flow %
14.05%
Top 10 Hldgs %
51.86%
Holding
86
New
16
Increased
49
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
CS
Credit Suisse Group
CS
+$1.79M
2
NS
NuStar Energy L.P.
NS
+$1.64M
3
BCS icon
Barclays
BCS
+$1.41M
4
MLPA icon
Global X MLP ETF
MLPA
+$988K
5
EXPE icon
Expedia Group
EXPE
+$960K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$408K
2
IMGN
Immunogen Inc
IMGN
+$357K
3
CMG icon
Chipotle Mexican Grill
CMG
+$273K
4
SRPT icon
Sarepta Therapeutics
SRPT
+$265K
5
PPLI
People Inc
PPLI
+$249K

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Consumer Discretionary 11.02%
3 Financials 10.96%
4 Communication Services 6.9%
5 Energy 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPLI
26
People Inc
PPLI
$3.1B
$900K 0.92%
41,205
-11,118
-21% -$249K
EXPE icon
27
Expedia Group
EXPE
$37.3B
$886K 0.91%
+7,400
New +$960K
MU icon
28
Micron Technology
MU
$991B
$884K 0.9%
21,498
+498
+2% +$21.5K
JUNO
29
DELISTED
Juno Therapeutics, Inc.
JUNO
$836K 0.85%
18,281
-1,020
-5% -$50.9K
BLUE
30
DELISTED
bluebird bio
BLUE
$811K 0.83%
352
+37
+12% +$75.1K
GBT
31
DELISTED
Global Blood Therapeutics, Inc.
GBT
$768K 0.78%
19,516
+2,024
+12% +$75.6K
AERI
32
DELISTED
Aerie Pharmaceuticals
AERI
$745K 0.76%
12,466
-2,111
-14% -$128K
AUPH icon
33
Aurinia Pharmaceuticals
AUPH
$2.11B
$707K 0.72%
156,126
+16,189
+12% +$89.9K
MRK icon
34
Merck
MRK
$318B
$675K 0.69%
12,568
+346
+3% +$19.2K
PTLA
35
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$665K 0.68%
13,657
+1,416
+12% +$71.6K
ZGNX
36
DELISTED
Zogenix, Inc.
ZGNX
$652K 0.67%
16,268
+1,686
+12% +$64.8K
TSRO
37
DELISTED
TESARO, Inc.
TSRO
$647K 0.66%
7,806
+2,560
+49% +$251K
DO
38
DELISTED
Diamond Offshore Drilling
DO
$636K 0.65%
34,238
+1,238
+4% +$20.1K
SPPI
39
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$616K 0.63%
+32,526
New +$589K
ABT icon
40
Abbott
ABT
$187B
$610K 0.62%
10,688
– –
NETI
41
DELISTED
Eneti Inc.
NETI
$549K 0.56%
7,978
+197
+3% +$13.7K
PMT
42
PennyMac Mortgage Investment
PMT
$842M
$521K 0.53%
32,417
-9,628
-23% -$156K
CXO
43
DELISTED
CONCHO RESOURCES INC.
CXO
$515K 0.53%
3,425
+125
+4% +$17.4K
LCI
44
DELISTED
Lannett Company, Inc.
LCI
$490K 0.5%
+5,281
New +$515K
CMG icon
45
Chipotle Mexican Grill
CMG
$41.5B
$487K 0.5%
84,200
-45,800
-35% -$273K
PTEN icon
46
Patterson-UTI
PTEN
$3.76B
$477K 0.49%
20,750
+750
+4% +$15.5K
AAMC
47
DELISTED
Altisource Asset Management Corp
AAMC
$473K 0.48%
9,860
– –
CTRA
48
DELISTED
Coterra Energy
CTRA
$472K 0.48%
16,496
+596
+4% +$16.4K
GSK icon
49
GSK
GSK
$106B
$462K 0.47%
10,409
+1,079
+12% +$49.8K
AZN icon
50
AstraZeneca
AZN
$250B
$452K 0.46%
6,506
+674
+12% +$45.5K
1
2
3 4

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Kazazian Asset Management held 86 positions worth $97.9M, up 20% from $81.7M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Kazazian Asset Management deployed $13.7M of net new capital in Q4 2017, opening 16 new positions and adding to 49 existing holdings. Its largest new stake was Credit Suisse Group: 108,000 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Biogen, an estimated $408K trimmed.

  • Kazazian Asset Management's largest Q4 2017 buy was Credit Suisse Group: 108,000 shares worth $1.93M.
  • Kazazian Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $846K increase.
  • Kazazian Asset Management's biggest Q4 2017 reduction was Biogen, cutting an estimated $408K.
  • Kazazian Asset Management fully exited Immunogen Inc in Q4 2017, selling an estimated $357K.
  • Kazazian Asset Management's ten largest holdings make up 52% of its $97.9M portfolio in Q4 2017.
  • Kazazian Asset Management opened 16 new positions and closed 4 in Q4 2017.
  • Kazazian Asset Management's portfolio value rose 20% quarter-over-quarter to $97.9M.

Based on Kazazian Asset Management's 13F filing for Q4 2017, filed 15 Feb 2018.